Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
SN Compr Clin Med ; 2(9): 1306-1312, 2020.
Article in English | MEDLINE | ID: covidwho-716460

ABSTRACT

This paper briefly analyzes COVID-19 cases during Wuhan lockdown and travel restrictions on 23 January 2020 to 23 June 2020, which included total confirmed, in critical condition, deaths, recovered, and suspected cases in China. Results showed that there were 28,942 suspected cases on February 8, 2020, at the peak; then, it almost declined continually to only several cases. Total confirmed cases were more than 80,000 on March 1, 2020, but less than 84,000, and deaths were more than 3000 on March 4, 2020, but less than 4640, totally, thanks for the right public measures for COVID-19 in China, such as the Wuhan City lockdown and travel restrictions for isolation; positive screening and testing; and establishing a Huoshenshan hospital, a Leishenshan hospital, and a number of Fangcang shelter hospitals, traditional Chinese medicine and a combination of Chinese and western medicine, and the launch of the clinical trials of antiviral drugs (Lianhua Qingwen, remdesivir, and chloroquine). In addition, the iRT-ABCDEF program is very useful to control domestic, imported, and asymptomatic cases. Cases in critical condition decrease continually after the peak of 11,977 cases on February 18, 2020, and recovered cases increase continually to over 78,400 cases due to these right public measures and effective treatments. In recent months, there are only 2 deaths and only about ten cases in critical condition. All in all, these public measures in China are confirmed to be very effective and are worth conducting in countries worldwide.

SELECTION OF CITATIONS
SEARCH DETAIL